Health & Fitness
Health and Fitness
Health and Fitness
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
Teva to Present at the Morgan Stanley Global Healthcare Conference
JERUSALEM--([ BUSINESS WIRE ])--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference with Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd., presenting on Tuesday, September 14, 2010 in New York City.
| What: | Teva Presentation at the Morgan Stanley Global Healthcare Conference in New York City | |||
| Who: | Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd. | |||
| When: | Tuesday, September 14, 2010 at 10:20am (ET) | |||
| Where: | [ http://www.corporateir.net/ireye/conflobby.zhtml?ticker=TEVA&item_id=3323455 ] or [ http://www.tevapharm.com/financial/ ] | |||
| How: | Live over the Internet -- log onto the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website. | |||
About Teva
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva's branded businesses focus on neurological, respiratory and women's health therapeutic areas as well as biologics. Teva's leading innovative product, Copaxone®, is the number one prescribed treatment for multiple sclerosis. Teva employs more than 40,000 people around the world and reached $13.9 billion in net sales in 2009.
